TOB-STOP-COP (TOBacco STOP in COPd trial): study protocol—a randomized open-label, superiority, multicenter, two-arm intervention study of the effect of “high-intensity” vs. “low-intensity” smoking cessation intervention in active smokers with chronic obstructive pulmonary disease

BACKGROUND: Cigarette smoking is the leading cause of chronic obstructive pulmonary disease (COPD), and it contributes to the development of many other serious diseases. Smoking cessation in COPD patients is known to improve survival and reduce the number of hospitalization-requiring acute exacerbat...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Trials
Auteurs principaux: Saeed, Mohamad Isam, Sivapalan, Pradeesh, Eklöf, Josefin, Ulrik, Charlotte Suppli, Pisinger, Charlotta, Lapperre, Therese, Tønnesen, Philip, Hoyer, Nils, Janner, Julie, Karlsson, Marie Lavesen, Bech, Charlotte Sandau, Marså, Kristoffer, Godtfredsen, Nina, Brøndum, Eva, Munk, Birgit, Raaschou, Merete, Browatzski, Andrea, Lütken, Pernille, Jensen, Jens-Ulrik Stæhr
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2020
Sujets:
Study Protocol
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7441548/
https://ncbi.nlm.nih.gov/pubmed/32825845
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-020-04653-z
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires